⌘K
Loading ticker…
Esperion Therapeutics, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Esperion Therapeutics, Inc. (ESPR) has a 3-month relative strength percentile of 60 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 65. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 0.5%, relative volume 1.27×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
60 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
ESPR is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $21M notional. Top 3 carry $44M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $21M |
| IWMiShares Russell 2000 ETF | 0.02% | $16M |
| VXFVanguard Extended Market ETF | 0.01% | $7M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.95% | $6M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $2M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $944K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ESPR Jan avg: -13.34% median: -13.51% win: 25% σ: 13.14% n: 4 2022-04-12 → 2026-05-29 | ESPR Feb avg: 2.06% median: -2.00% win: 25% σ: 10.27% n: 4 2022-04-12 → 2026-05-29 | ESPR Mar avg: -25.25% median: -16.75% win: 25% σ: 34.53% n: 4 2022-04-12 → 2026-05-29 | ESPR Apr avg: -19.97% median: -26.49% win: 20% σ: 12.88% n: 5 2022-04-12 → 2026-05-29 | ESPR May avg: 10.91% median: 3.03% win: 80% σ: 27.03% n: 5 2022-04-12 → 2026-05-29 | ESPR Jun avg: 8.10% median: 7.18% win: 100% σ: 6.71% n: 4 2022-04-12 → 2026-05-29 (current) | ESPR Jul avg: 12.99% median: 8.50% win: 75% σ: 22.75% n: 4 2022-04-12 → 2026-05-29 | ESPR Aug avg: 16.69% median: 15.60% win: 75% σ: 33.43% n: 4 2022-04-12 → 2026-05-29 | ESPR Sep avg: -9.85% median: -10.01% win: 25% σ: 23.73% n: 4 2022-04-12 → 2026-05-29 | ESPR Oct avg: 10.41% median: 16.71% win: 75% σ: 17.93% n: 4 2022-04-12 → 2026-05-29 | ESPR Nov avg: 28.79% median: 36.14% win: 75% σ: 32.99% n: 4 2022-04-12 → 2026-05-29 | ESPR Dec avg: 22.16% median: -7.37% win: 25% σ: 68.76% n: 4 2022-04-12 → 2026-05-29 |